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Changes in renal blood flow reserve after angioplasty of renal
artery stenosis in hypertensive patients.
Background. Intra-arterial Doppler is a recent technique
which allows assessment of distal vascular disease using mea-
surements of intrarenal blood flow velocities. The purpose of
this study was to evaluate intrarenal hemodynamics and renal
blood flow reserve before and after percutaneous translumi-
nal angioplasty (PTA) in hypertensive patients with unilat-
eral atherosclerotic renal artery stenosis using intra-arterial
Doppler.
Methods. Intra-arterial Doppler was performed during arte-
riography in 19 hypertensive patients (12 men; mean age, 64 ±
8 years) in “normal” and in “stenotic” kidneys at baseline, on
isosorbide dinitrate, and after selective intra-renal papaverine
injection, before, and after PTA. Doppler parameters analyzed
were average peak velocity, maximum peak velocity, end dias-
tolic velocity, and renal blood flow (RBF). Changes in Doppler
parameters after papaverine injection were also analyzed.
Results. The major results were (1) the significant reduction
in RBF distal to the stenosis, (2) the lack of arteriolar reactivity
in response to papaverine distal to the stenosis, (3) the immedi-
ate recovery of arteriolar reactivity after PTA, associated with
restoration of RBF in the revascularized kidneys, and (4) no
change in arteriolar reactivity in response to papaverine in the
“normal” kidneys following PTA.
Conclusion. Ours results highlighted the benefit of endovas-
cular Doppler to evaluate (1) RBF reserve, and (2) the reper-
cussion of the stenosis on the distal vascularization.
Atherosclerotic renal disease (ARD) is an increasing
cause of chronic renal failure [1–3]. ARD includes prox-
imal renal stenosis, and intraparenchymal lesions such
as ischemic nephropathy, arteriolar lesions, and crystal
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cholesterol emboli [1–3]. Renal artery stenosis (RAS) is
a cause of secondary hypertension, and can be treated
by percutaneous transluminal angioplasty (PTA) in most
cases [3].
Stenosis of the ostial or proximal portions of the re-
nal arteries can be detected by various noninvasive tech-
niques [3–9]. Evaluation of the consequences of RAS
on the distal kidney is difficult because clinical markers
(blood pressure, microalbuminuria), morphologic mark-
ers (kidney size), and functional markers (creatinine
clearance, intrarenal resistive index measurements using
echo-Doppler) do not provide early and/or accurate de-
tection of intraparenchymal lesions [2, 9, 10]. Selective
renal angiography can detect distal disease with “dead
tree” images, but here again, it is a sign of advanced
vascular damage.
Because anatomic evaluation of the distal parenchy-
mal vessels is difficult, vasculature can be assessed from
its function [11–17]. The fall in glomerular filtration rate
(GFR) on scintigraphic studies may be a useful functional
marker of distal vascular disease [11–14]. Intra-arterial
Doppler is another recent technique that allows assess-
ment of possible distal vascular disease by measurement
of intrarenal blood flow velocities combined with quanti-
tative angiography. Recently, intracoronary Doppler has
been used to assess coronary blood flow reserve in pa-
tients with coronary artery disease [18, 19]. This technique
demonstrated that isolated coronary microvascular dis-
ease in patients with angiographically normal coronary
arteries may be responsible for myocardial ischemia [19].
Furthermore, coronary microvascular disease may ex-
acerbate myocardial ischemia in patients with epicardial
coronary stenoses with stable angina or acute coronary
syndromes [19]. Applications of Doppler techniques
for the study of peripheral circulation have been less
widespread. Published works appear limited to feasibil-
ity studies and reports of basal renal blood flow (RBF)
in healthy arteries or in arteries with significant stenosis
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[7, 20–26]. These studies have demonstrated the existence
of renal arteriolar vasodilatation to papaverine. These
changes in RBF may be interpreted as functional markers
of RBF reserve (i.e., the capacity of the renal circulation
to increase RBF) [24–26].
The purpose of the current work was to assess (1) the
functional consequences of RAS on RBF reserve, and
(2) the immediate effects of PTA on arteriolar reactivity
in hypertensive patients with unilateral atherosclerotic
RAS, using a combination of intra-arterial Doppler and
quantitative angiography.
METHODS
Population
Over a period of 12 months, 19 hypertensive patients
(12 men; mean age 64 ± 8 years) with a significant os-
tial unilateral renal atheroslerotic stenosis were enrolled
in this study after informed consent. The protocol was
approved by the University of Lille Ethical Committee.
To minimize the potential confounding effects of vasoac-
tive drugs on renal vasomotor responses, antihyperten-
sive treatment was changed 3 weeks before the Doppler
study; the new treatment included only nitrate derivatives
and calcium channel blockers (nicardipine 100 mg/day).
These were subsequently discontinued 24 hours before
angiography.
Patients with severe hypertensive or diabetic
nephrosclerosis were previously excluded on the basis of
noninvasive techniques such as the renal resistive index.
Patients with asymmetric kidney size and/or with small
kidney (renal length <8 cm) were also excluded. Renal
length was assessed by spiral computed tomography
angiography (CTA) (Somaton Plus 4A; Siemens,
Erlanger, Germany) [27]. Finally, because the existence
of accessory renal arteries can complicate renal reserve
evaluation, patients with accessory renal arteries were
excluded.
Digital subtraction renal angiography and stenting
Renal angiography (Integris V 3000; Philips, Best, The
Netherlands) confirmed the significant ostial atheroscle-
rotic RAS. Before angiograghy, the patients’ hydratation
status was guaranteed by not restricting fluid intake, and
by administering 500 mL of intravenous saline.
When necessary, intra-arterial blood pressure gradient
was obtained to confirm the significance of the RAS; a
mean systolic blood pressure gradient ≥20 mm Hg across
the lesion was considered significant [13, 27]. Quantita-
tive angiography was performed using Philips software.
The vessel diameter (d) (mm) was measured at the level
of the tip of the Doppler wire and cross-sectional area
(CSA) (cm2) was calculated as p d2/4. The total volume
of contrast injection ranged from 100 mL to 150 mL.
We used anatomic and usual clinical criteria to deter-
mine the need for renal revascularization [3, 10]. Stenoses
were considered significant when the arterial lumen was
reduced by more than 50% in diameter, representing a
reduction of >70% of the CSA [3]. PTA and stenting
were performed using 5 to 7 mm diameter balloons and
balloon-expandable stents. The technical outcome was
evaluated on completion angiogram. Patients were main-
tained on acetyl salicylic acid (160 mg daily) and ticlopi-
dine (500 mg daily during 6 weeks). No evidence of renal
infarct was depicted on the completion angiogram and
on the 6-month spiral CTA.
Flow measurements
Flow measurements were performed using a 0.018 inch
J Doppler-tipped Flowire, which was advanced into the
renal artery through a catheter. The external tip of the
Doppler wire was connected to a Cardiometrics FloMap
(Cardiometrics, Mountainview, CA, USA). The Doppler
spectral forms were optimized by slowly rotating the J-
shaped guidewire and monitoring both the image screen
and auditory Doppler signal. A printer was used to
record the Doppler spectrum and provide real time read-
outs of average peak velocity (APV) (cm/sec), maximum
peak velocity (MPV) (cm/sec), and end diastolic velocity
(EDV) (cm/sec) (Fig. 1).
The reproducibility of blood flow measurements was
previously reported [24–26]. Doppler measurements do
not differ significantly between left and right renal arter-
ies [24–26]. RBF was determined as RBF (mL/min) =
APV (cm/sec) × CSA (cm2) × 60 (beats·min−1).
Mean blood pressure was assessed with a 4 F catheter
placed in the aorta and in both renal arteries, in order
to calculate renal resistances (RR) (i.e., arteriolar resis-
tance) from the equation: RR = average blood pressure
(mm Hg)/RBF (mL/min). Baseline Doppler parameters,
blood pressure, and heart rate were recorded after isosor-
bide dinitrate injection (ISDN), 1 mg diluted in 10 mL
of 0.9% normal saline (Risordan, Rhoˆne Poulenc Rorer,
France) (baseline state) (b). This allowed us to study the
effects of papaverine on the “stenotic” renal microcircu-
lation under conditions of standardized vasomotor tone
[24, 25].
A bolus of papaverine (40 mg diluted in 9 mL of 0.9%
normal saline) was injected into the stenotic renal artery,
before and after stenting. Doppler, heart rate, and blood
pressure measurements were repeated at the time of the
maximal effect on APV and MPV (i.e., 5 to 10 seconds af-
ter the injection) (hyperhemic state) (h). After a 5-minute
interval, quantitative angiography and Doppler measure-
ments were performed to ensure flow had returned to
baseline values. The catheter was then repositioned in the
“normal” renal artery to perform a similar comparative
Doppler study.
Mounier-Vehier et al: Renal blood flow reserve and percutaneous angioplasty 247
Fig. 1. A typical example of a Doppler record-
ing in the right artery at baseline (A) and after
injection of papaverine (B). The average peak
velocity is almost doubled after papaverine
injection.
The response to papaverine (i.e., delta d) was studied
as follows: d parameter = 100 × (h parameter/b param-
eter). Results were expressed as percentage values. We
assumed that changes in APV after papaverine injection
were equivalent to the renal reserve: d APV = h APV/b
APV × 100.
Statistical analysis
Statistical analysis provided a descriptive analysis of
the population (mean and standard deviations for nu-
merical parameters, frequencies for qualitative ones), and
a study of Spearman’s coefficients in order to correlate
clinical and morphologic parameters. The Doppler study
took into account the status of the renal artery (“stenotic”
or “normal”), the stenting effect and the papaverine ef-
fect. A nonparametric two-factor analysis of variance
for repeated measurements (ANOVA) was performed
at baseline to test the “stenosis” effect (stenotic versus
normal artery), the “stenting effect” (before versus af-
ter stenting), and the interaction between the two effects.
A two by two comparison of means was performed to
test the papaverine effect in both groups of arteries be-
fore and after stenting. The threshold significance level
(a risk) was set at 5%. Data were analyzed using SAS
software (SAS version 8.1, SAS Institute, Inc., Cary, NC,
USA).
RESULTS
Biologic and clinical findings
Clinical and laboratory findings are reported in Table 1.
No proteinuria or microalbuminuria was depicted.
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Table 1. Demographic characteristics of the study population
N = 19
Gener ratio male/female 12/7
Cardiovascular family history number (%) 9 (47)
History of hypertension >2 years number (%) 15 (79)
Cigarette smoking number (%) 13 (68)
Diabetes mellitus number (%) 6 (31)
Obesity (i.e., body masss index ≥25 kg/m2) number (%) 4 (21)
Dyslipidemia number (%) 14 (74)
Atheroslerotic sites >2 number (%) 13 (68)
Age years 64 ± 8
Duration of hypertension years 12 ± 9
Heart rate beats/minute 80 ± 17
Systolic blood pressure mm Hg 173 ± 24
Diastolic blood pressure mm Hg 91 ± 19
Pulse pressure mm Hg 82 ± 18
Body mass index kg/m2 27 ± 3
Serum creatinine mg/L 12 ± 4
Creatinine clearance mL/min 67 ± 29
Antihypertensive treatments number 2.5 ± 0.8
Serum potassium mmol/L 4.1 ± 0.5
Creatinine clearance was assessed with the Cockcroft-Gault formula.
Results are shown as mean ± standard deviation for numerical parameters;
frequency and percentage for categoric parameters.
Cardiovascular risk factors were, in decreasing order, dys-
lipidemia, smoking, diabetes mellitus, and obesity (body
mass index >25 kg/m2). Concomitant coronary artery in-
sufficiency was present in four cases, carotid arterial dis-
ease in seven cases, and lower limb arteritis in 11 cases;
18 patients had an atheromatous abdominal aorta, and
three patients had a history of ischemic stroke; 68% of
the patients were suffering from multivessel atheroma-
tous disease. Nine patients out of 19 were receiving more
than three antihypertensive treatments at the time of
inclusion.
Renal angiography
Thirty-eight arteries and 19 unilateral RAS (nine lo-
cated on the right renal artery) were examined. Two
stenoses were evaluated between 50% and 70%, and 17
stenoses were ≥70%. Stenting was carried out success-
fully in all cases. Mean renal length was 95 ± 12 mm on
the right, and 94 ± 13 mm on the left. Renal artery di-
ameter after ISDN injection was 6.2 ± 0.5 mm on the
right, and 6.3 ± 0.8 mm on the left (P = NS). Injection of
papaverine had no effect on the renal artery diameter.
Doppler parameters
Doppler measurements should not be performed in ar-
eas of turbulence, and the guide is sometimes difficult
to position correctly. Therefore, recording the maximal
spectrum can be difficult. Subsequently, we were unable
to investigate six stenotic arteries and three normal re-
nal arteries. The mean values of Doppler parameters at
baseline and after papaverine injection are reported in
Tables 2 and 3. Mean blood pressure recorded during
arteriography was 99 ± 27 mm Hg before stenting, and
110 ± 21 mm Hg after.
Table 2. Doppler parameters values before (T0), and after
angioplasty (T1), at baseline (b)
Before angioplasty After angioplasty
N0 S0 N1 S1
N = 16 N = 15 N = 13 N = 18 Interaction
b APV 36 ± 9 27 ± 9 35 ± 9 33 ± 15 0.01
b MPV 85 ± 30 64 ± 32 81 ± 42 70 ± 30 0.001
b EDV 19 ± 6 16 ± 7 20 ± 4 17 ± 9 NS
b RBF 1085 ± 232 835 ± 280 1061 ± 266 1027 ± 552 0.005
b RR 0.10 ± 0.03 0.13 ± 0.05 0.11 ± 0.03 0.13 ± 0.08 0.03
Abbreviations are: N, normal renal artery; S, stenotic renal artery; APV,
average peak velocity [mean envelope over 1 second (cm/sec)]; MPV, maximum
peak velocity [mean envelope over 1 second (cm/sec)]; EDV, end diastolic
velocity [mean envelope over 1 second (cm/sec)]; RBF, renal blood flow
(mL/min); RR, renal (i.e., arteriolar) resistances.
Two-factor analysis of variance for repeated measurements. Results are shown
as mean ± standard deviation.
Results are shown as P value. Results significant if P < 0.05.
Table 3. Hyperhemic changes in Doppler parameters (d) in normal
renal artery group (N), and in stenotic renal artery group (S), before
(T0) and after angioplasty (T1)
Before angioplasty After angioplasty
N0 S0 N1 S1
N = 16 N = 15 N = 13 N = 18
d APV 156 ± 42 126 ± 32 159 ± 21 178 ± 46
d MPV 143 ± 32 120 ± 25 154 ± 36 171 ± 36
d EDV 164 ± 69 138 ± 40 154 ± 23 203 ± 76
d RBF 156 ± 42 126 ± 32 159 ± 21 178 ± 46
d RR 68 ± 16 84 ± 18 64 ± 9 60 ± 17
Abbreviations are: APV, average peak velocity [mean envelope over
1 second (cm/sec)]; MPV, maximum peak velocity [mean envelope over 1 second
(cm/sec)]; EDV, end diastolic velocity [mean envelope over 1 second (cm/sec)];
RBF, renal blood flow (mL/min); RR, renal (i.e., arteriolar) resistances.
Results are expressed as percentage values.
Basal Doppler parameters
Before stenting, APV and MPV were significantly
lower in the “stenotic renal artery” (SRA) group com-
pared to the “normal renal artery” (NRA) group (P =
0.01 and P = 0.001, respectively). RBF was 250 mL/min
lower (P = 0.005), and RR were higher in the SRA group
(P = 0.03) compared to the NRA group (Table 2).
There were no significant changes in Doppler param-
eters in the two renal groups following stenting. RBF
recovered to a comparable level after stenting in both
groups (Table 2).
Hyperhemic effect after papaverine injection
Changes after papaverine injection were significantly
different in the SRA group and NRA group (Fig. 2). In
the SRA group, the magnitude of the response to pa-
paverine before stenting was half as great, both for APV
and for RBF, compared to the NRA group (P = 0.02 and
P = 0.02, respectively). In the NRA group, the arteriolar
response to papaverine remained unchanged after stent-
ing. Conversely, in the SRA group, stenting significantly
and immediately changed arteriolar reactivity to papaver-
ine, producing an increase in flow velocity, which was as-
sociated with a reduction in renal resistances (P = 0.003).
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Fig. 2. Renal vasodilatator reserve before and after stenting Doppler
average peak velocity (d APV) for the stenotic [S] and normal renal
arteries [N]. The P values correspond to the results of two by two com-
parisons of means between N and S kidneys before (T0), and after (T1)
angioplasty. d APV are APV changes (N0/N1, NS; S0/S1, 0.003; N0/S0,
0.02; N1/S1, NS).
The increase in RBF was directly dependent on the APV,
as renal artery diameter was maintained constant by the
ISDN injection (P = 0.003). Reactivity to papaverine was
higher in the SRA group compared to the NRA group,
although this difference did not reach statistical signifi-
cance. Thus, the renal vasodilator reserve for the stenotic
kidney was 1.1 before and 2.6 after stenting. It was 1.6
and 1.7 for the normal kidney.
DISCUSSION
The major results of this study were (1) the significant
reduction in RBF distal to the stenosis, (2) the reduction
in arteriolar reactivity to papaverine distal to the steno-
sis, (3) the immediate recovery of arteriolar reactivity af-
ter stenting, associated with RBF restoration in the SRA
group, and (4) and no change in arteriolar reactivity to
papaverine following stenting in the NRA group.
Prior injection of ISDN was designed to inhibit varia-
tions in vasomotor tone in the main renal artery. These
variations could have interfered with the evaluation of
distal vascularization through a “flow dependent” me-
chanical effect. The ISDN injection therefore maintained
constant the renal artery diameter. Papaverine, which was
used to test arteriolar reactivity, is a potent and specific
arteriolar dilator, with a very short half-life (about 40
seconds). Papaverine selectively inhibits arteriolar vaso-
motility on vasoconstricted arteries, and in arteries in an
intermediate vasoconstriction-vasodilatation state.
RBF distal to the RAS in the SRA group was on av-
erage 250 mL/min lower compared to the NRA group.
The decreased RBF demonstrated that, in case of severe
RAS (>75%), the kidney could not maintain constant
blood flow, despite arteriolar vasodilation. In the setting
of moderate stenoses (50% to 70%), a loss of arteriolar
reactivity was observed, associated with maintained re-
nal flow. The decrease in RBF may be a hemodynamic
criterion of severity [3]. The immediate restoration of
RBF following PTA was principally due to the arterial
lumen restoration. Such results were not reported by
Privat et al [21] and Savader, Lund, and Osterman [22]
and Savader, Lund, and Venbrux [23], who used different
methods (i.e., the Doppler recording on the same side as
the stenosis). Previous studies reported vasodilatation of
preglomerular arterioles in response to papaverine. The
parameters that appeared useful to study were not the
baseline Doppler values, but the changes of these values
in response to papaverine.
The arteriolar vasodilatation resulted in increased
mean and maximal Doppler velocities, increased RBF,
and decreased renal resistances [24–26]. The most impor-
tant Doppler variable was the renal vasodilator reserve.
The lack of arteriolar response to papaverine at baseline
in the SRA group could indicate a state of maximal va-
sodilatation in afferent arterioles, and therefore optimal
involvement of renal reserve. Alternatively, it could rep-
resent a state of fixed vasoconstriction due to microvascu-
lar disease. Since morphologic studies have demonstrated
the existence of cortical atrophy in patients with essential
hypertension [6, 29] and in patients with atheromatous or
dysplastic RAS [27, 30], we could not exclude, in the cur-
rent study, that the two mechanisms were associated. We
also observed that these distal abnormalities were still
reversible despite a history of hypertension (16 patients
reported a duration of hypertension >2 years), and the
atheromatous pattern of the lesions.
We noted that the amplitude of the response in the
revascularized kidneys (i.e., vasodilator reserve) tended
to exceed the response of the “normal” kidneys, which,
conversely, were similar to those in a subgroup of patients
with essential hypertension [25]. These results would sup-
port the hypothesis of the existence of fixed distal le-
sions in the nonstenotic kidney group [29–31]; conversely,
stenotic kidneys should be more protected by the steno-
sis, according to the hypothesis of Goldblatt et al [32].
RAS may be underestimated by quantitative angiogra-
phies since this technique induces the study of image
projection. Anterior-posterior lesions are also sometimes
badly visualized. Consequently, the Doppler techniques
can be used for clinical decision-making.
The fall in renal reserve may be interpreted as a marker
of hemodynamically significant stenosis. This marker may
be considered a further criterion for significance, in addi-
tion to “classic” anatomic and clinical criteria.
Moreover, the restoration of the arteriolar reactivity
postrevascularization indicates the presence of nonfixed
lesions, which could represent an additional retrospective
argument for the assessment of the procedure in terms of
renal benefit.
Study limits
Endovascular Doppler did not directly measure re-
nal vasodilatator reserve. As reported in the Results
section, Doppler measurements should not be per-
formed in nine cases; we took into consideration these
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limitations in the study. We did not have anatomic ev-
idence of structural arteriolar disease. It would require
histologic investigation, which would be impossible to jus-
tify on ethical grounds. The iodine contrast could have an
impact on renal vasoconstriction (Hexabrix; Guerbet,
Villepinte, France) (320 mg iodine/mL). However, this
vasoconstrictor effect is of very short duration, about 1
minute and it should not interfere with the Doppler study.
For ethical consideration, we could not include healthy
volunteers. The current number of patients was also small
compared to previously performed coronary studies. Fi-
nally, the cross-sectional design of the study does not al-
low us to conclude on the early diagnostic value or on the
prognostic value of these functional markers.
CONCLUSION
Ours results highlighted the interest of endovascular
Doppler in order to evaluate the distal repercussions of
RAS. At baseline, differences in Doppler variables be-
tween the normal and stenotic renal arteries were diag-
nosed. Renal artery stenting improved these variables.
The loss of arteriolar reactivity after papaverine injection
could be a marker of renal reserve involvement. These
Doppler indices, especially d APV, may lead us to re-
view the severity criteria of RAS. The relevance of such
Doppler parameters should be validated by prospective
studies, including a study of renal resistive index [17] and
a study of cortical thickness [6, 27, 29–31].
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